AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 33342522
Drug: Additional $40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Additional $40 in monthly SNAP benefits per child under age 5 years (treatment group)
Trial: 32437787
Drug: Heithersay classification
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heithersay classification and treatment decision by independent evaluators.
Trial: 34621707
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg twice a day
Trial: 33274528
Drug: Maximal removal
RxNorm normalized name: Spirulina maxima preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maximal removal torque evaluated at the end of treatment in Group 3.
Trial: 33676294
Drug: Prior therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prior therapy
Trial: 34315379
Drug: Instructions of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Instructions of Daily Care (IDC)
Trial: 32065415
Drug: Oral controlled-release
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral controlled-release ketamine tablets (60, 120, or 240 mg)
Trial: 32682556
Drug: Norepinephrine 6
RxNorm normalized name: NOREPINEPHRINE 64MCG/ML/D5 INJ BAG 250ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norepinephrine 6 μg ml−1
Trial: 32682556
Drug: Phenylephrine 100
RxNorm normalized name: phenylephrine 100 mcg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylephrine 100 μg ml−1
Trial: 33164784
Drug: Garcinia cambogia
RxNorm normalized name: Garcinia Cambogia Fruit
DrugBank: Garcinia gummi-gutta fruit (DB14365)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garcinia cambogia extract (GCE)/(−) – hydroxycitric acid (HCA) 1500/750 mg under fasted condition
Trial: 33164784
Drug: Garcinia cambogia
RxNorm normalized name: Garcinia Cambogia Fruit
DrugBank: Garcinia gummi-gutta fruit (DB14365)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garcinia cambogia extract (GCE)/(−) – hydroxycitric acid (HCA) 1500/750 mg under fed condition after a high calorie breakfast (600 calories)
Trial: 32833285
Drug: AST-guided therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AST-guided therapy (bismuth-containing quadruple therapy guided by antimicrobial susceptibility testing)
Trial: 32833285
Drug: PMH-guided therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PMH-guided therapy (personal medication history-guided therapy)
Trial: 32833285
Drug: Both AST
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both AST and PMH therapies
Trial: 34058023
Drug: Plasma transfusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma transfusion (10–15 cc/kg)
Trial: 32933625
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of recombinant human interferon α1b in addition to intravenous drip of acyclovir (observation group)
Trial: 32933625
Drug: Intravenous drip
RxNorm normalized name: DRIP COLLECTOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous drip of acyclovir (control group)
Trial: 32510158
Drug: Resistant starch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistant starch type 3 (RS‐WM; 22 or 26 g/d for females and males, respectively)
Trial: 32236818
Drug: Nigella sativa
RxNorm normalized name: NIGELLA SATIVA SEED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nigella sativa 500 mg once daily
Trial: 33878556
Drug: Probiotic capsule
RxNorm normalized name: GNP Probiotic Capsule
DrugBank: Bifidobacterium longum (DB19248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic capsule (PC; n = 25) containing probiotic strains
Trial: 33878556
Drug: Control capsule
RxNorm normalized name: Azo Men Bladder Control Capsules(obs)
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control capsule (CC; n = 20) containing a matching placebo
Trial: 35555136
Drug: Nitrate-rich beetroot
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate-rich beetroot juice (300 mg/70 mL) consumed acutely and for 7 days
Trial: 35599917
Drug: 30 mg.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg.kg‐1 carnosine and anserine ingestion 60 minutes before performance (Study A)
Trial: 35599917
Drug: 30 mg.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg.kg‐1 carnosine and anserine (Study B)
Trial: 35599917
Drug: 30 mg.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg.kg‐1 carnosine and anserine, placebo, or antihistamines (Study C)
Trial: 32478660
Drug: mHealth app
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mHealth app prescription intervention
Trial: 34690120
Drug: Combined tDCS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined tDCS (1.5 mA, 20 min, 12 sessions) + Mindfulness-based substance abuse treatment (MBSAT)
Trial: 34690120
Drug: Mindfulness-based substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-based substance abuse treatment (MBSAT)
Trial: 35634610
Drug: Group-A: Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group-A: Capsule Amoxicillin 1 gm; Tablet Clarithromycin 500 mg; Capsule Omeprazole 20 mg, twice daily for two weeks.
Trial: 35634610
Drug: Group-B: Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group-B: Capsule Amoxicillin 1 gm; Tablet Vonoprazan 20 mg, twice daily for two weeks.
Trial: 35971757
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of both framing strategies
Trial: 35908558
Drug: chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: chemotherapy alone (pemetrexed and cisplatin)
Trial: 34033804
Drug: IV iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV iron 1,000 mg
Trial: 33992228
Drug: Whole-body vibration
RxNorm normalized name: Insects (whole body), mite dermatophagoides farinae
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-body vibration training (35 Hz) twice a week for 12 weeks
Trial: 33617953
Drug: No targeted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No targeted therapy (Control)
Trial: 33000490
Drug: Neoadjuvant pyrotinib
RxNorm normalized name: Pyrotinib
DrugBank: Pyrotinib (DB14993)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant pyrotinib in combination with epirubicin and cyclophosphamide followed by docetaxel and trastuzumab (P + EC-TH)
Trial: 33290317
Drug: Measures of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Measures of interference with activities of daily living
Trial: 33735590
Drug: 60 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 μg HB vaccine
Trial: 34120835
Drug: Inulin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inulin (10 g/d for females; 15 g/d for males)
Trial: 34120835
Drug: Maltodextrin (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maltodextrin (6 g/d for females; 9 g/d for males)
Trial: 32682668
Drug: Sufentanil (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil (5 mcg bolus 1 minute before larger dose)
Trial: 32682668
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (equal volume 1 minute before larger dose)
Trial: 32402773
Drug: Ice cube
RxNorm normalized name: N'ICE Cubes 8 MG Oral Lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ice cube absorption (group 2)
Trial: 32402773
Drug: Ice cube
RxNorm normalized name: N'ICE Cubes 8 MG Oral Lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ice cube absorption along with cold vapor application (group 3)
Trial: 34911609
Drug: Family rehabilitation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family rehabilitation treatment performed by parents under the guidance of professionals
Trial: 34559118
Drug: EZJDR (Erzhu
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EZJDR (Erzhu Jiedu Recipe) administered twice a day after meals for 48 weeks
Trial: 35194433
Drug: Melatonin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (3 mg sublingual twice daily, then 9 mg single dose 30 min before apheresis session and then 3 mg twice daily from +1 until engraftment)
Trial: 36171519
Drug: 23.4% NaCl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23.4% NaCl intravenous push
Trial: 33507958
Drug: High-dose corticosteroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose corticosteroid pulse therapy (HDCPT) using at least 1.5mg/kg/24h of methylprednisolone or dexamethasone equivalent
Trial: 32780797
Drug: Osteopathic Manipulative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Osteopathic Manipulative Treatment (OMT), n=16
Trial: 35142586
Drug: Online Vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Online Vaccine Education Program (VEP) videos
Trial: 35142586
Drug: Science-based video
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Science-based video unrelated to vaccines
Trial: 33099032
Drug: Teriparatide (human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teriparatide (human parathyroid hormone 1–34) for 18 months
Trial: 35818141
Drug: Timothy grass
RxNorm normalized name: Timothy grass
DrugBank: Phleum pratense top (DB14179)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timothy grass SLIT-tablet
Trial: 33039291
Drug: Subcutaneous immunoglobulin
RxNorm normalized name: immunoglobulin A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous immunoglobulin (IgPro20) 0.2 g/kg bodyweight
Trial: 33039291
Drug: Subcutaneous immunoglobulin
RxNorm normalized name: immunoglobulin A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous immunoglobulin (IgPro20) 0.4 g/kg bodyweight
Trial: 35422766
Drug: 60 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 g/d of whey protein hydrolysate
Trial: 35422766
Drug: Maltodextrin with
RxNorm normalized name: Maltodextrin
DrugBank: Maltodextrin (DB12583)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maltodextrin with high (30 g/d) or low (10 g/d) dietary fiber intake
Trial: 33899634
Drug: Marketed vaginal
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marketed vaginal gel (Metron®)
Trial: 34789067
Drug: Motivational Interviewing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motivational Interviewing integrated with Cognitive Behavioral Therapy (MI-CBT)
Trial: 34789067
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy alone (CBT-alone)
Trial: 36307514
Drug: Combustible cigarettes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combustible cigarettes (CC)
Trial: 35274710
Drug: SOC +
RxNorm normalized name: Sorafenib
DrugBank: Sorafenib (DB00398)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SOC + IO (mFOLFOX6 + Bevacizumab + Avelumab + CEA-targeted vaccine)
Trial: 33799307
Drug: Novel oral
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Novel oral nutritional supplement (whey and casein protein, ursolic acid, free branch‐chained amino acids, vitamin D) for 12 weeks
Trial: 33799307
Drug: Standard oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard oral nutritional supplement for 12 weeks
Trial: 34429364
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg rhTNK-tPA (to a maximum of 40 mg)
Trial: 34429364
Drug: 0.25 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/kg rhTNK-tPA (to a maximum of 40 mg)
Trial: 34429364
Drug: 0.32 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.32 mg/kg rhTNK-tPA (to a maximum of 40 mg)
Trial: 34429364
Drug: 0.9 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9 mg/kg rt-PA (to a maximum of 90 mg)
Trial: 34254658
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg intrathecal meperidine
Trial: 34254658
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg intrathecal meperidine
Trial: 34254658
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg intrathecal meperidine
Trial: 34254658
Drug: 70 mg
RxNorm normalized name: silybin 70 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70 mg intrathecal meperidine
Trial: 33383570
Drug: High carbohydrate
RxNorm normalized name: High carbohydrate food
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High carbohydrate diet (MAX = 10 g/kg body mass CHO daily)
Trial: 33383570
Drug: Moderate carbohydrate
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate carbohydrate control diet (CON = 6 g/kg body mass CHO daily)
Trial: 35325871
Drug: Argentine tango
RxNorm normalized name: Argentine canola pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Argentine tango dance intervention (90 minutes, twice a week for 12 weeks)
Trial: 33822469
Drug: SAR425899 (0.12,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SAR425899 (0.12, 0.16 or 0.20 mg)
Trial: 33822469
Drug: liraglutide (1.80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: liraglutide (1.80 mg)
Trial: 34374425
Drug: WRSS1 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WRSS1 vaccine (3 doses of 3 × 106 CFU)
Trial: 34374425
Drug: WRSS1 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WRSS1 vaccine (3 doses of 3 × 105 CFU)
Trial: 34374425
Drug: WRSS1 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WRSS1 vaccine
Trial: 36451722
Drug: Dexamethasone (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (8 mg) added to 10 mg hyperbaric bupivacaine 0.5% with 5 µg sufentanil
Trial: 36451722
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received 10 mg hyperbaric bupivacaine 0.5% with 5 µg sufentanil and 2 ml normal saline
Trial: 35279142
Drug: Daily supportive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily supportive text messages (Text4Support) and mental health peer support
Trial: 35279142
Drug: Daily supportive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily supportive text messages (Text4Support)
Trial: 35838507
Drug: Biofeedback (BF)
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Biofeedback (BF) and Manual Therapy (MT) with Postural Exercises (PE)
Trial: 35838507
Drug: Biofeedback (BF)
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Biofeedback (BF) and Manual Therapy (MT) with Transcutaneous Electrical Nerve Stimulation (TENS)
Trial: 34726808
Drug: NB-OMP (NB-UVB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NB-OMP (NB-UVB and dexamethasone oral mini-pulse therapy)
Trial: 34348954
Drug: Recovery-focused therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recovery-focused therapy (RfT) for older adults with BD; specific dosage and duration not mentioned.
Trial: 34215025
Drug: Efpeglenatide (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Efpeglenatide (4 or 6 mg weekly subcutaneous injections)
Trial: 35120127
Drug: CC-11050 (PDE4i)
RxNorm normalized name: CC
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC-11050 (PDE4i)
Trial: 35120127
Drug: auranofin (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: auranofin (oral gold salt)
Trial: 33588908
Drug: Intravenous alteplase
RxNorm normalized name: Alteplase
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous alteplase administration (IVT) at a dosage of 0.9 mg/kg followed by endovascular treatment (EVT)
Trial: 33588908
Drug: Direct endovascular
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct endovascular treatment (EVT)
Trial: 33588908
Drug: Intravenous alteplase
RxNorm normalized name: Alteplase
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous alteplase administration (IVT) followed by EVT
Trial: 34129389
Drug: Aerosol therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosol therapy (specific medications not detailed)
Trial: 34129389
Drug: Mucus-regulating agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mucus-regulating agents
Trial: 34129389
Drug: Aerosol therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosol therapy (general)
Trial: 34171967
Drug: Group-based psychosocial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group-based psychosocial intervention with weekly sessions for up to four weeks.
Trial: 35805451
Drug: Clinical Pilates
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical Pilates exercises combined with conventional physical therapy (CPT)
Trial: 35959221
Drug: Hysteroscopic cold
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hysteroscopic cold broad sword play + drospirenone and ethinylestradiol tablets
Trial: 35959221
Drug: Hysteroscopic cold
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hysteroscopic cold broad sword play + estrogen and progestin sequential therapy
Trial: 34225318
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Auditory and Audiovisual Training (AT/AVT)
Trial: 39531231
Drug: Brief Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brief Cognitive Behavioral Therapy (BCBT)
Trial: 35986197
Drug: FDC (aripiprazole/divalproex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDC (aripiprazole/divalproex sodium 5/500 mg)
Trial: 36070132
Drug: TPIP 112.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPIP 112.5 µg (n=6)
Trial: 36070132
Drug: TPIP 225
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPIP 225 µg QD for 7 days (n=6)
Trial: 36070132
Drug: TPIP 112.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPIP 112.5 µg QD for 4 days followed by 225 µg QD for 3 days (n=6)
Trial: 36070132
Drug: Placebo (n=2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (n=2 for single-dose, n=4 for multiple-dose)
Trial: 32454191
Drug: Intensity Modulated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensity Modulated Radiation Therapy with Deep Inspiration Breath Hold (IMRT-DIBH)
Trial: 36471430
Drug: Traditional maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional maintenance ICS treatment and symptom-driven SABA
Trial: 33300950
Drug: Capecitabine (650
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capecitabine (650 mg/m2 twice a day for 1 year)
Trial: 35538396
Drug: Point-of-care (PoC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Point-of-care (PoC) HCV RNA testing and direct-acting antiviral (DAA) treatment
Trial: 32349879
Drug: Ceftazidime/Avibactam (CAZ-AVI)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime/Avibactam (CAZ-AVI) followed by colistin + high-dose meropenem
Trial: 32349879
Drug: Meropenem followed
RxNorm normalized name: Meropenem
DrugBank: Meropenem (DB00760)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Meropenem followed by colistin + high-dose meropenem
Trial: 33527721
Drug: 600 mg/d
RxNorm normalized name: Rebetron, single dose 600 mg/day oral and injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg/d Alpha Lipoic Acid (ALA)
Trial: 33257420
Drug: Non-use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-use of Metformin
Trial: 36133316
Drug: Initial L‐T4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial L‐T4 dose of 10‐12.5 μg/kg/day (Low)
Trial: 36133316
Drug: Initial L‐T4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial L‐T4 dose of 12.6‐15 μg/kg/day (High)
Trial: 36133316
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment schemes (Low and High)
Trial: 33624275
Drug: Intravenous Tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous Tranexamic Acid (TXA) administered as 1 gram bolus and 1 gram every 6 hours for 48 hours
Trial: 33624275
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered in the same way as TXA
Trial: 35180779
Drug: Behavioral sleep
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral sleep treatment
Trial: 35180779
Drug: Treatment-as-usual attention-controlled
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-as-usual attention-controlled comparison group
Trial: 33691506
Drug: Daily steps
RxNorm normalized name: PostDay One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Daily steps at 2 months poststroke (≥1632 daily steps)
Trial: 33691506
Drug: Daily steps
RxNorm normalized name: PostDay One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Daily steps at 2 months and balance (Berg Balance Scale score)